{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T23:56:21Z","timestamp":1783814181591,"version":"3.55.0"},"update-to":[{"DOI":"10.1002\/14651858.cd013181","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000}}],"reference-count":109,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd013181.pub2","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T15:44:35Z","timestamp":1583768675000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Self-administered versus provider-administered medical abortion"],"prefix":"10.1002","volume":"2020","author":[{"given":"Katherine","family":"Gambir","sequence":"first","affiliation":[{"name":"Population Council; Poverty, Gender and Youth Program; One Dag Hammarskj\u00f6ld Plaza New York New York USA 10017"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caron","family":"Kim","sequence":"additional","affiliation":[{"name":"World Health Organization; Department of Reproductive Health and Research; 20 Avenue Appia Geneva Switzerland 1211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly Ann","family":"Necastro","sequence":"additional","affiliation":[{"name":"Massachusetts General Hospital; Boston Massachusetts USA 02114"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bela","family":"Ganatra","sequence":"additional","affiliation":[{"name":"World Health Organization; Department of Reproductive Health and Research; 20 Avenue Appia Geneva Switzerland 1211"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thoai D","family":"Ngo","sequence":"additional","affiliation":[{"name":"Population Council; Poverty, Gender and Youth Program; One Dag Hammarskj\u00f6ld Plaza New York New York USA 10017"},{"name":"Population Council; The GIRL Center; New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"issue":"5","key":"10.1002\/14651858.CD013181.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.contraception.2004.05.005","article-title":"Results and lessons learned from a small medical abortion clinical study in Turkey","volume":"70","author":"Akin","year":"2004","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1363\/3907913","article-title":"Acceptability and feasibility of mifepristone-misoprostol for menstrual regulation in Bangladesh","volume":"39","author":"Alam","year":"2013","journal-title":"International Perspectives on Sexual and Reproductive Health"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ijgo.12356","article-title":"Mifepristone-misoprostol for menstrual regulation in public sector facilities in Bangladesh","volume":"140","author":"Alam","year":"2018","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/13625180500361058","article-title":"Mifepristone medical abortion in Albania: results from a pilot clinical research study","volume":"11","author":"Bracken","year":"2006","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijgo.2009.09.027","article-title":"Home administration of misoprostol for early medical abortion in India","volume":"108","author":"Bracken","year":"2010","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.gyobfe.2003.11.005","article-title":"Use of misoprostol for medical abortion: a trial of the acceptability for home use","volume":"32","author":"Dagousset","year":"2004","journal-title":"Gyn\u00e9cologie, Obst\u00e9trique & Fertilit\u00e9"},{"issue":"9266","key":"10.1002\/14651858.CD013181.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(00)04563-3","article-title":"Can women in less-developed countries use a simplified medical abortion regimen?","volume":"257","author":"Elul","year":"2001","journal-title":"Lancet"},{"issue":"9266","key":"10.1002\/14651858.CD013181.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/S0140-6736(00)04563-3","article-title":"Can women in less-developed countries use a simplified medical abortion regimen?","volume":"257","author":"Elul","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD013181.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.contraception.2004.06.012","article-title":"Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study","volume":"70","author":"Hajri","year":"2004","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/aogs.12815","article-title":"Home use of misoprostol for early medical abortion in a low resource setting: secondary analysis of a randomized controlled trial","volume":"95","author":"Iyengar","year":"2016","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijgo.2009.02.007","article-title":"Acceptability and feasibility of medical abortion in Nepal","volume":"106","author":"Karki","year":"2009","journal-title":"International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics"},{"issue":"5","key":"10.1002\/14651858.CD013181.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1177\/1933719116669055","article-title":"Efficacy, safety, and acceptability of low-dose mifepristone and self-administered misoprostol for ultra-early medical abortion: a randomized controlled trial","volume":"24","author":"Li","year":"2017","journal-title":"Reproductive Sciences"},{"issue":"8","key":"10.1002\/14651858.CD013181.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/j.1471-0528.2004.00209.x","article-title":"Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam","volume":"118","author":"Ngoc","year":"2004","journal-title":"BJOG"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijgo.2013.10.009","article-title":"Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria","volume":"125","author":"Okonofua","year":"2014","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"11-12","key":"10.1002\/14651858.CD013181.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.gyobfe.2009.07.016","article-title":"Medical abortion at home and at hospital: a trial of efficacy and acceptability","volume":"37","author":"Provansal","year":"2009","journal-title":"Gyn\u00e9cologie, Obst\u00e9trique & Fertilit\u00e9"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ijgo.2012.05.022","article-title":"Clinic-level introduction of medical abortion in Vietnam","volume":"119","author":"Raghavan","year":"2012","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"47","key":"10.1002\/14651858.CD013181.pub2-BIB0017|cit17","first-page":"185","article-title":"A randomized trial of hospital vs home self administration of vaginal misoprostol for medical abortion","volume":"12","author":"Shrestha","year":"2014","journal-title":"Kathmandu University Medical Journal"},{"issue":"5","key":"10.1002\/14651858.CD013181.pub2-BIB0018|cit18","first-page":"410","article-title":"Simplifying medical abortion: home administration of misoprostol","volume":"58","author":"Shuchita","year":"2008","journal-title":"Journal of Obstetrics and Gynecology of India"},{"issue":"26","key":"10.1002\/14651858.CD013181.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0968-8080(05)26207-9","article-title":"Study supports the introduction of early medical abortion in Turkey","volume":"13","author":"Akin","year":"2005","journal-title":"Reproductive Health Matters"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/13625180902916020","article-title":"Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually following 200 mg mifepristone.","volume":"14","author":"Akin","year":"2009","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ejogrb.2005.02.019","article-title":"Preference and acceptability of oral versus vaginal administration of misoprostol in medical abortion with mifepristone","volume":"123","author":"Arvidsson","year":"2005","journal-title":"European Journal of Obstetrics & Gynecoloy and Reproductive Biology"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.contraception.2003.08.019","article-title":"The medical abortion experiences of married and unmarried women in Tunis, Tunisia","volume":"69","author":"Blum","year":"2004","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.contraception.2015.06.026","article-title":"A prospective, non-randomized study of home use of mifepristone for medical abortion in the U.S","volume":"92","author":"Chong","year":"2015","journal-title":"Contraception"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijgo.2014.09.022","article-title":"A prospective open-label study of home use of mifepristone for medical abortion in Nepal","volume":"128","author":"Conkling","year":"2015","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD013181.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1097\/01.AOG.0000258298.35143.d2","article-title":"Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial","volume":"109","author":"Creinin","year":"2007","journal-title":"Obstetrics and Gynecology"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.contraception.2012.06.006","article-title":"Results of a 4-year study on 15,447 medical abortions provided by privately practicing general practitioners and gynecologists in France","volume":"87","author":"Gaudu","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(01)00171-8","article-title":"Outpatient second trimester pregnancy termination","volume":"63","author":"Gonzalez","year":"2001","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD013181.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.contraception.2005.12.011","article-title":"Simultaneous very low dose mifepristone and vaginal misoprostol for medical abortion","volume":"73","author":"Kapp","year":"2006","journal-title":"Contraception"},{"issue":"4","key":"10.1002\/14651858.CD013181.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/jfprhc-2016-101652","article-title":"Comparing two regimens of intravaginal misoprostol with intravaginal gemeprost for second-trimester pregnancy termination: a randomised controlled trial","volume":"43","author":"Koh","year":"2017","journal-title":"Journal of Family Planning and Reproductive Health Care"},{"issue":"6","key":"10.1002\/14651858.CD013181.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/13625187.2014.933956","article-title":"Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerbaijan","volume":"19","author":"Louie","year":"2014","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0031|cit31","first-page":"593","article-title":"Medical abortion practices among private providers in Vietnam","volume":"5","author":"Park","year":"2013","journal-title":"International Journal of Women's Health"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijgo.2016.02.018","article-title":"Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10 weeks of pregnancy in Kazakhstan","volume":"134","author":"Platais","year":"2016","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3109\/13625187.2013.763225","article-title":"Acceptability and feasibility of the use of 400 mug of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan","volume":"18","author":"Raghavan","year":"2013","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"issue":"5","key":"10.1002\/14651858.CD013181.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0010-7824(84)90016-7","article-title":"Randomized comparison of prostaglandin treatment in hospital or at home with vacuum aspiration for termination of early pregnancy","volume":"29","author":"Rosen","year":"1984","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.contraception.2012.10.021","article-title":"Acceptability of home use of mifepristone for medical abortion","volume":"88","author":"Swica","year":"2013","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0036|cit36","doi-asserted-by":"crossref","unstructured":"Tsereteli T Chong E Louie K Bokhua Z Winikoff B Acceptability and feasibility of 400mug buccal misoprostol after 200mg mifepristone for early medical abortion in Georgia Gynuity Health Projects 2016 367 71","DOI":"10.1080\/13625187.2016.1211632"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0037|cit37","unstructured":"NCT02219100 Acceptability and feasibility of a demedicalized medical abortion regimen in the Caucasus https:\/\/ClinicalTrials.gov\/show\/NCT02219100"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0038|cit38","unstructured":"NCT02981030 Acceptability and feasibility of a simplified medical abortion service delivery in Western Ukraine clinicaltrials.gov\/ct2\/show\/NCT02981030"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0039|cit39","unstructured":"NCT02985229 Acceptability and feasibility of medical abortion in Singapore clinicaltrials.gov\/ct2\/show\/NCT02985229"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0040|cit40","unstructured":"NCT03346629 Outpatient service for mid-trimester termination of pregnancy clinicaltrials.gov\/ct2\/show\/NCT03346629"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0041|cit41","unstructured":"NCT03727308 Study of clinic-based versus self-use of medical abortion pills (MOC) clinicaltrials.gov\/ct2\/show\/NCT03727308"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0042|cit42","unstructured":"Banerjee SK Kalayanwala S Manning V Andersen KL Raj R Das A Is self-use of medical abortion a viable option?: A systematic review of global evidence with a special focus on India www.ipasdevelopmentfoundation.org\/publications\/is-self-use-of-medical-abortion-a-viable-option-a-systematic-review-of-global-evidence-with-a-special-focus-on-india.html 2018"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1503\/cmaj.071399","article-title":"Clandestine induced abortion: prevalence, incidence and risk factors among women in a Latin American Country","volume":"180","author":"Bernab\u00e9-Ortiz","year":"2009","journal-title":"Canadian Medical Association Journal"},{"issue":"4","key":"10.1002\/14651858.CD013181.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.18203\/2320-1770.ijrcog20181351","article-title":"Self administered medical abortion pills: evaluation of the clinical outcome and complications among women presenting with unsupervised pill intake to a tertiary care hospital in Malwa Region of Punjab, India","volume":"7","author":"Bhalla","year":"2018","journal-title":"International Journal of Reproduction, Contraception, Obstetrics and Gynecology"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijgo.2012.03.039","article-title":"Comparison of misoprostol-only and combined mifepristone-misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam","volume":"118","author":"Blum","year":"2012","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0046|cit46","unstructured":"Veritas Health Innovation Covidence systematic review software"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0047|cit47","unstructured":"Darroch J Singh S Estimating unintended pregnancies averted from couple-years of protection (CYP) Guttmacher Institute: www.guttmacher.org\/sites\/default\/files\/page_files\/guttmacher-cyp-memo.pdf 2011"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0048|cit48","unstructured":"Deeks JJ Higgins JP Altman DG editor(s) on behalf of the Cochrane Statistical Methods Group Chapter 9: Analysing data and undertaking metaanalyses. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa0809146","article-title":"Rates of serious infection after changes in regimens for medical abortion","volume":"361","author":"Fjersted","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.contraception.2017.08.002","article-title":"Assessing the safety and effectiveness of medical abortion medications purchased from pharmacies: methodological challenges and emerging data","volume":"97","author":"Footman","year":"2018","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/sifp.12049","article-title":"Medical abortion provision by pharmacies and drug sellers in low- and middle income countries: a systematic review","volume":"49","author":"Footman","year":"2018","journal-title":"Studies in Family Planning"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0052|cit52","doi-asserted-by":"crossref","unstructured":"Footman K LaChance NT Using evidence to improve quality of pharmacy-delivered medical abortion. STEP UP case study London: Marie Stopes International 2018","DOI":"10.31899\/rh4.1025"},{"issue":"10110","key":"10.1002\/14651858.CD013181.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1016\/S0140-6736(17)31794-4","article-title":"Global, regional, and subregional classification of abortions by safety, 2010-14: estimates from a Bayesian hierarchical model","volume":"390","author":"Ganatra","year":"2017","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ijgo.12717","article-title":"Availability and prescription of misoprostol for medical abortion in community pharmacies and associated factors in Accra, Ghanna","volume":"144","author":"Ganle","year":"2019","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3126\/njog.v10i1.13188","article-title":"A study of complications following self-administration with medical abortion pills","volume":"10","author":"Giri","year":"2015","journal-title":"Nepal Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0056|cit56","unstructured":"Sch\u00fcnemann H Bro\u017cek J Guyatt G Oxman A editor(s) Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013 Available from gdt.guidelinedevelopment.org\/app\/handbook\/handbook.html"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijgo.2007.03.009","article-title":"Reducing maternal mortality due to elective abortion: potential impact of misoprostol in low-resource settings","volume":"98","author":"Harper","year":"2007","journal-title":"Internaltion Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.ijgo.2015.07.008","article-title":"Client-pharmacy worker interactions regarding medical abortion in Zambia in 2009 and 2011","volume":"132","author":"Hendrickson","year":"2016","journal-title":"International Journal of Gynaecology and Obstetrics"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0059|cit59","unstructured":"Higgins JP Green S editor(s) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0060|cit60","unstructured":"Higgins JP Altman DG Sterne JA editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Churchill R, Chandler J, Cumpston MS, editor(s), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0061|cit61","doi-asserted-by":"crossref","unstructured":"Higgins JP Thomas J Chandler J Cumpston M Li T Page MJ editor(s) Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). The Cochrane Collaboration, 2019 Available from www.training.cochrane.org\/handbook","DOI":"10.1002\/9781119536604"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijgo.2013.07.037","article-title":"Availability and provision of misoprostol and other medicines for menstrual regulation among pharmacies in Bangladesh via mystery client survey","volume":"124","author":"Huda","year":"2014","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.contraception.2012.10.020","article-title":"Misoprostol in women's hands: a harm reduction strategy for unsafe abortion","volume":"87","author":"Hyman","year":"2013","journal-title":"Contraception"},{"issue":"6","key":"10.1002\/14651858.CD013181.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/humrep\/17.6.1477","article-title":"A prospective randomized, double-blinded, placebo-controlled trial comparing mifepristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy","volume":"17","author":"Jain","year":"2002","journal-title":"Human Reproduction"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"133-42","DOI":"10.1363\/3813312","article-title":"Feasibility of expanding the medication abortion provider base in India to include ayurvedic physicians and nurses","volume":"38","author":"Jejeebhoy","year":"2012","journal-title":"International Perspectives on Sexual and Reproductive Health"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.contraception.2017.05.019","article-title":"Putting abortion pills into women's hands: realizing the full potential of medical abortion","volume":"97","author":"Jelinska","year":"2018","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"29-40","DOI":"10.1016\/S0010-7824(99)00115-8","article-title":"The efficacy of medical abortion: a meta-analysis","volume":"61","author":"Kahn","year":"2000","journal-title":"Contraception"},{"issue":"11","key":"10.1002\/14651858.CD013181.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1111\/1471-0528.14646","article-title":"A research agenda for moving early medical pregnancy termination over the counter","volume":"124","author":"Kapp","year":"2017","journal-title":"BJOG"},{"issue":"5","key":"10.1002\/14651858.CD013181.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/13625180903128609","article-title":"Home abortion implies radical changes for women","volume":"14","author":"Kero","year":"2009","journal-title":"European Journal of Contraception & Reproductive Health Care"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0070|cit70","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007223.pub4","article-title":"Medical treatments for incomplete miscarriage","author":"Kim","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD013181.pub2-BIB0071|cit71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002855.pub4","article-title":"Medical methods for first trimester abortion","author":"Kulier","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9999","key":"10.1002\/14651858.CD013181.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(15)60497-4","article-title":"Women and health: the key for sustainable development","volume":"386","author":"Langer","year":"2015","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1363\/3707511","article-title":"How often and under which circumstances do Mexican pharmacy vendors recommend misoprostol to induce an abortion?","volume":"37","author":"Lara","year":"2011","journal-title":"International Perspectives on Sexual and Reproductive Heatlh"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0074|cit74","article-title":"Chapter 4: Searching for and selecting studies","volume-title":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors)","author":"Lefebvre","year":"Cochrane, 2019. Available from\u00a0www.training.cochrane.org\/handbook"},{"issue":"7","key":"10.1002\/14651858.CD013181.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/aogs.12398","article-title":"Medical abortion with mifepristone and home administration of misoprostol up to 63 days' gestation","volume":"96","author":"Lokeland","year":"2014","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"10","key":"10.1002\/14651858.CD013181.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD013181.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.contraception.2017.09.016","article-title":"Exploring the feasibility of obtaining mifepristone and misoprostol from the internet","volume":"97","author":"Murtagh","year":"2018","journal-title":"Contraception"},{"issue":"5","key":"10.1002\/14651858.CD013181.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2471\/BLT.10.084046","article-title":"Comparative effectiveness, safety and acceptability of medical abortion at home and in a clinic: a systematic review","volume":"89","author":"Ngo","year":"2011","journal-title":"Bulletin of the World Health Organization"},{"issue":"4","key":"10.1002\/14651858.CD013181.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2471\/BLT.14.143990","article-title":"Nurse versus physician-provision of early medical abortion in Mexico: a randomized controlled non-inferiority trial","volume":"93","author":"Olavarrieta","year":"2015","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0120637","article-title":"Delivering medical abortion at scale: a study of the retail market for medical abortion in Madhya Pradesh, India","volume":"10","author":"Powell-Jackson","year":"2015","journal-title":"PLOS One"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.contraception.2012.06.011","article-title":"First-trimester medical abortion with mifepristone 200 mg and misoprostol: a systematic review","volume":"87","author":"Raymond","year":"2013","journal-title":"Contraception"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/AOG.0000000000003017","article-title":"Efficacy of misoprostol alone for first-trimester medical abortion: a systematic review","volume":"133","author":"Raymond","year":"2019","journal-title":"Obstetrics and Gynecology"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/jfprhc-2013-100821","article-title":"Pharmacy works\u2019 knowledge and provision of medication for termination of pregnancy in Kenya","volume":"42","author":"Reiss","year":"2016","journal-title":"Journal of Family Planning and Reproductive Health Care"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0084|cit84","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0191174","article-title":"Effectiveness and safety of early medication abortion provided in pharmacies by auxiliary nurse-midwives: a non-inferiority study in Nepal","volume":"13","author":"Rocca","year":"2018","journal-title":"PLOS One"},{"issue":"7","key":"10.1002\/14651858.CD013181.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1471-0528.2012.03310.x","article-title":"Acceptability of misoprostol-only medical termination of pregnancy compared with vacuum aspiration: an international, multicentre trial","volume":"119","author":"Rodriguez","year":"2012","journal-title":"International Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0087|cit87","unstructured":"Ryan R Hill S How to GRADE the quality of the evidence. CCCG cccrg.cochrane.org\/author-resources"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0088|cit88","unstructured":"Sch\u00fcnemann HJ Oxman AD Higgins JP Vist GE Glasziou P Akl E on behalf of the Cochrane GRADEing Methods Group and the Cochrane Statistical Methods Group Chapter 11: Completing \u2018Summary of findings\u2019 tables and grading the confidence in or quality of the evidence. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors), Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017), The Cochrane Collaboration, 2017 Available from www.training.cochrane.org\/handbook"},{"issue":"1","key":"10.1002\/14651858.CD013181.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijgo.2015.11.017","article-title":"Insights from an expert group meeting on the definition and measurement of unsafe abortion","volume":"134","author":"Sedgh","year":"2016","journal-title":"International Journal of Gynaecology and Obstetrics"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0090|cit90","first-page":"107","article-title":"How much supervision is necessary for women taking mifepristone and misoprostol for early medical abortion?","volume":"4","author":"Shannon","year":"2008","journal-title":"Womens Heatlh"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"269","DOI":"10.33314\/jnhrc.v16i3.1378","article-title":"Safety, efficacy and acceptability of early first trimester abortion using oral mifepristone and sublingual misoprostol","volume":"16","author":"Shrestha","year":"2018","journal-title":"Journal of Nepal Health Research Council"},{"issue":"9","key":"10.1002\/14651858.CD013181.pub2-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1111\/1471-0528.13552","article-title":"Facility-based treatment for medical complications resulting from unsafe pregnancy termination in the developing world, 2012: a review of evidence from 26 countries","volume":"123","author":"Singh","year":"2016","journal-title":"BJOG"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0093|cit93","doi-asserted-by":"crossref","unstructured":"Singh S Remez L Sedgh G Kwok L Onda T Abortion worldwide 2017: uneven progress and unequal access Guttmacher Institute: www.guttmacher.org\/report\/abortion-worldwide-2017 2018","DOI":"10.1363\/2018.29199"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1057\/jphp.2012.11","article-title":"Roles of pharmacists in expanding access to safe and effective medical abortion in developing countries: a review of literature","volume":"33","author":"Sneeringer","year":"2012","journal-title":"Journal of Public Health Policy"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0095|cit95","first-page":"1705","article-title":"Early medical abortion with self-administered low-dose mifepristone in combination with misoprostol","volume":"44","author":"Song","year":"2018","journal-title":"Journal of Obstetrics and Gynaecology"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomized studies for interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s13063-015-1035-0","article-title":"How to assess success of treatment when using multiple doses: the case for misoprostol for medical abortion","volume":"16","author":"Suec","year":"2015","journal-title":"Trials"},{"issue":"44 Suppl 1","key":"10.1002\/14651858.CD013181.pub2-BIB0098|cit98","first-page":"104","article-title":"Pharmacy workers in Nepal can provide the correct information about using mifepristone and misoprostol to women seeking medication to induce abortion","volume":"22","author":"Tamang","year":"2015","journal-title":"Reproductive Health Matters"},{"issue":"20","key":"10.1002\/14651858.CD013181.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.contraception.2017.09.004","article-title":"Medical abortion can be provided safely and effectively by pharmacy workers trained within a harm reduction framework: Nepal","volume":"97","author":"Tamang","year":"2018","journal-title":"Contraception"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ejogrb.2018.08.014","article-title":"Acceptability and feasibility of outpatient medical abortion with mefepristone and misoprostol up to 70 days gestation in Singapore","volume":"229","author":"Tan","year":"2018","journal-title":"European Journal of Obstetrics, Gynecology, and Reproductive Biology"},{"issue":"3","key":"10.1002\/14651858.CD013181.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0010-7824(99)00078-5","article-title":"Estimating the efficacy of medical abortion","volume":"60","author":"Trussell","year":"1999","journal-title":"Contraception"},{"issue":"47","key":"10.1002\/14651858.CD013181.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.rhm.2016.06.008","article-title":"Self-management of medical abortion: a qualitative evidence synthesis","volume":"24","author":"Wainwright","year":"2016","journal-title":"Reproductive Health Matters"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0103|cit103","unstructured":"World Health Organization Unsafe abortion. Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008 www.who.int\/reproductivehealth\/publications\/unsafe_abortion\/9789241501118\/en\/ 2011"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0104|cit104","unstructured":"World Health Organization Safe abortion: technical and policy guidance for health systems, 2nd Edition www.who.int\/reproductivehealth\/publications\/unsafe_abortion\/9789241548434\/en\/"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0105|cit105","unstructured":"World Health Organization Clinical practice handbook for safe abortion www.who.int\/reproductivehealth\/publications\/unsafe_abortion\/clinical-practice-safe-abortion\/en\/"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0106|cit106","unstructured":"World Health Organization Health worker roles in providing safe abortion care and post-abortion contraception apps.who.int\/iris\/bitstream\/handle\/10665\/181041\/9789241549264_eng.pdf?sequence=1 2015"},{"key":"10.1002\/14651858.CD013181.pub2-BIB0107|cit107","unstructured":"World Health Organization Medical management of abortion www.who.int\/reproductivehealth\/guideline-medical-abortion-care\/en\/ 2018"},{"issue":"2","key":"10.1002\/14651858.CD013181.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-9378(97)70511-8","article-title":"Safety, efficacy, and acceptability of medical abortion in China, Cuba, and India: a comparative trial of mifepristone-misoprostol versus surgical abortion","volume":"176","author":"Winikoff","year":"1997","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"11","key":"10.1002\/14651858.CD013181.pub2-BIB0109|cit109","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013181","article-title":"Self-administered versus provider-administered medical abortion","author":"Gambir\u00a0\u00a0K","year":"2018","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T08:05:39Z","timestamp":1683792339000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD013181.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Fertility Regulation Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":109,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd013181.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]}}}